The Intersection of Technology, HAART Adherence, and Drug Abuse Treatment Washington Marriott Wardman Park Washington, DC. Agenda
|
|
- Deirdre Campbell
- 5 years ago
- Views:
Transcription
1 The Intersection of Technology, HAART Adherence, and Drug Abuse Treatment Washington Marriott Wardman Park Washington, DC Thursday, March 4, 8:00 a.m. 5:00 p.m. Friday, March 5, 8:00 a.m. 1:00 p.m. Agenda The purpose of this meeting is to encourage multidisciplinary collaboration between social scientists, medical (physician/nurse) researchers, and technology experts to develop and refine mobile instrumentation, e-health technology, and software as means of fostering adherence to HIV treatment regimens and access to care in real time. Specifically, NIDA hopes to stimulate research on the development and feasibility of such interventions (e.g., mobile enabling technologies, Ecological Momentary Assessment [EMA], enhanced Medication Event Monitoring System, computer software, portable digital devices, and cell phones and/or Digital Assistant Devices) to foster adherence to HIV treatment regimens among substance-abusing populations in natural timeframes and contexts. Given the prevalence of HIV among active drug users and the high rates of nonadherence to HIV treatment regimens, together with the relatively consistent adherence necessary to maintain virological suppression, there is a critical need for valid and reliable methods to assess adherence and a need to develop, refine, and improve interventions in the context of drug abuse. Because HIV and substance abuse disorders represent two overlapping and chronic conditions, the generation and use of specific technological devices may offer an integrated and streamlined approach to target the complex treatment needs of substance users with HIV. To date, much of the emerging literature on the use of technologies to monitor adherence to HAART and related treatment and care regimens among HIV+ populations has not included active drug users. In addition, much of the adherence data from HIV+ drug-abusing samples are retrospective in nature, and thus it is not possible to intervene as the nonadherent behaviors occur. Recent data suggest that some technologies, such as EMA and electronic diary reports, can be used in treating drug-abusing (such as methadone-maintained) populations, specifically in recording cue exposure, cravings, and mood in the hours before cocaine and/or heroin use. As such, technologies that can simultaneously monitor and assess adherence (particularly to help identify those most in need of intervention) and advance the delivery and efficacy of interventions to foster adherence in real time offer an innovative modality to target the numerous clinical needs of drug-abusing populations with HIV. The topics to be addressed at this meeting include: 1. How feasible is it to develop, utilize, implement, and/or disseminate these technologies among drug-abusing populations with HIV? What are the potential barriers to adopting these approaches to these populations, and what resources/approaches are needed to overcome them? Are there particular settings (e.g., community health agencies, drug treatment clinics, needle exchange sites) in which this would be most viable? 2. Which groups and approaches are the most likely candidates for efficacious use of these technologies? What subgroups of drug-abusing populations with HIV are most suitable (e.g., prisoners leaving correction facilities and transitioning back to communities; or those already receiving specific behavioral and/or other interventions, such as DOT)? 3. What secondary benefits and innovative applications (e.g., HIV prevention, such as decreasing HIV-risk behaviors) may be developed as a result of adherence-related technologies?
2 4. What principles should guide the development and funding of research on technology to achieve a balance between the costs (in money and time) of research and the need to mount interventions (some of which might cost little but have the potential for at least modest public health impact)? Thursday, March 4 Day 1 8:00 8:30 a.m. Registration 8:30 8:50 a.m. Welcome and Introductions Jacques Normand, Ph.D. Director, AIDS Research Program 8:50 10:10 a.m. Session I: Overview 10:10 10:30 a.m. Break Shoshana Y. Kahana, Ph.D. Program Official, Behavioral and Integrative Treatment Branch Highly Active Antiretroviral Therapy and Survival in HIV-Infected Injection Drug Users: Implications for the Critical Role of Adherence Robert S. Hogg, Ph.D. Simon Fraser University/BC Centre for Excellence in HIV/AIDS Vancouver, British Columbia, Canada Interventions Targeting Medication Adherence and Drug Use for HIV+ Men: Perspectives from an Academic/Outpatient Clinic Jeffrey Parsons, Ph.D. Co-Director, Center for HIV/AIDS Educational Studies and Training Hunter College Interventions Targeting Medication Adherence and Drug Use for HIV+ Criminal Justice Populations Frederick L. Altice, M.D., and Sandra Springer, M.D. School of Medicine, Yale University New Haven, CT Considerations for Continued Development of Behavioral Interventions Targeting HIV Treatment Adherence Gregory M. Lucas, M.D., Ph.D. Division of Infectious Diseases Johns Hopkins University School of Medicine Baltimore, MD
3 10:30 am-12:00 pm Session II: Harnessing Real Time Technology: Implications for Monitoring Drug Cues/Cravings and HIV Treatment Adherence (Each scheduled talk also will include a demonstration of relevant technology discussed) 12:00 1:30 p.m. Lunch (on your own) Self-Monitoring Applications and Implications for Interventions Targeting Drug Abuse and HIV Treatment Adherence Mary Jane Rotheram-Borus, Ph.D. Center for HIV Identification, Prevention, and Treatment Services University of California at Los Angeles Los Angeles, CA Real-Time Electronic Diary Reports of Cue Exposure, Mood, and Drug Use! Kenzie Preston, Ph.D. Intramural Research Program Baltimore, MD Novel Approaches to Monitoring Adherence to HIV Therapy Jessica Haberer, M.D. Massachusetts General Hospital Boston, MA Biosensing and Wireless Technologies to Detect Drug Use and/or to Promote Adherence to Drug Abuse and HIV Treatment Edward W. Boyer, M.D., Ph.D. University of Massachusetts Medical School Worcester, MA 1:30 2:45 p.m. Group Discussion Lisa Onken, Ph.D. Branch Chief, Behavioral and Integrative Treatment Branch 2:45 4:00 p.m. Session III: Other Technologies that Promote or Monitor HIV Care and/or Treatment Adherence Impact of Frontline SMS, Mobile Phones, and Text Messaging on Health Care Delivery in Rural Malawi Josh Nesbit FrontlineSMS:Medic \+/ Washington, DC The Development of a Web-Based Program to Improve Adherence to HIV/AIDS Medications among Drug Abusers in a Community Clinic Royer F. Cook, Ph.D. ISA Associates, Inc. Arlington, VA CFAR Network of Integrated Clinical Systems (CNICS): The Use of Real- Time Patient-Centered Clinical Metrics for Substance Abuse and HIV Care Stephen L. Boswell, M.D.
4 4:00 4:15 p.m. Break Fenway Health/Harvard Medical School Boston, MA Collaboration with Developers: A Two-Way Learning Experience Vesta Brue Inventor and Lead Developer, MedSignals LLC San Antonio, TX 4:15 5:30 p.m. Group Discussion Lisa Marsch, Ph.D. (Facilitator) Julia H. Arnsten, M.D., M.P.H. (Facilitator) Albert Einstein College of Medicine Montefiore Medical Center Bronx, NY 5:30 p.m. Closing Remarks and Adjournment Friday, March 5 Day 2 8:15 8:30 a.m. Registration 8:30 8:50 a.m. Review Day 1 8:50 10:30 a.m. Session IV: Exploring Opportunities to Develop and Disseminate Adherence- Promoting Technologies Creating a Shared, Open, and Scalable Platform for Intervention Innovation Deborah Estrin, Ph.D. Director, Center for Embedded Networked Sensing University of California Los Angeles Los Angeles, CA Future Considerations and Lessons Learned from Internet-Based Interventions for HIV/STI Prevention Lisa Marsch, Ph.D. Substance Use, ART Adherence, and the Development of Class-Specific Antiretroviral Resistance: Implications for Future Interventions Edward M. Gardner, M.D. University of Colorado at Denver Denver Public Health Denver, CO Small Business Innovation Research (SBIR) and Technology Transfer (STTR) Programs Cathrine A. Sasek, Ph.D. Office of Science Policy and Communications
5 10:30 10:45 a.m. Break Fostering Public Partner Partnerships Shawnmarie Mayrand-Chung, Ph.D. Public-Private Partnership Program, Office of Science Policy National Institutes of Health 10:45 a.m.-12:15 p.m. Session V: Future Directions and Charting Recommendations for Developing, Implementing, and Evaluating Adherence-Promoting Technologies Continued Group Discussion Synthesis and Generation of Recommendations Lisa Marsch, Ph.D. (Facilitator) Julia H. Arnsten, M.D., M.P.H. (Facilitator) Albert Einstein College of Medicine Montefiore Medical Center Bronx, NY 12:15 p.m. 12:30 p.m. Wrap-up and Adjournment
Chronic illness and medication adherence in substance users: challenges and opportunities for research fellows FIT 2014 Cape Cod, MA
Chronic illness and medication adherence in substance users: challenges and opportunities for research fellows FIT 2014 Cape Cod, MA Julia H. Arnsten, MD, MPH Professor of Medicine, Epidemiology, and Psychiatry
Outline. Successful Integration of Hepatitis Vaccination Services into Programs for High-Risk Adults An Update of State-Based Programs
Successful Integration of Hepatitis Vaccination Services into Programs for High-Risk Adults An Update of State-Based Programs Joanna Buffington, MD, MPH Division of Viral Hepatitis National Immunization
CLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016
CLINICAL PATHWAY TRACK AGENDA TUESDAY, AUGUST 23, 2016 MORNING PLENARY LECTURES: LIBERTY BALLROOM (M4) 9:00 9:15 AM Welcome and Introductions Conference Co-Chairs: Laura W. Cheever, MD, ScM; Michael S.
Multimedia Appendix 1. Treatment and disease management Overview of papers mhealth articles
Multimedia Appendix 1. Treatment and disease management Overview of papers mhealth articles Research Country and Sampl e size Device Aims Key effects reference USA [1] 8 Voice To evaluate the practicality
Special thanks to: United States Environmental Protection Agency, as well as the 2017 Nutrient Permitting Workshop Planning Committee
Purpose: This meeting is intended to help support states and EPA to further identify challenges & barriers to nutrient permitting program implementation, highlight opportunities for program improvement
HHS Federal Partners Integrated Care Meeting. State of the Art: Research, Models, Promising Practices and Sustaining Integrated Care
HHS Federal Partners Integrated Care Meeting State of the Art: Research, Models, Promising Practices and Sustaining Integrated Care Date: June 22 & 23, 2017 Day 1: 10:00 am 4:30 pm EST; Day 2: 9:30 am
PRELIMINARY RYAN WHITE HIV/AIDS PROGRAM CLINICAL CARE CONFERENCE AGENDA
PRELIMINARY RYAN WHITE HIV/AIDS PROGRAM CLINICAL CARE CONFERENCE AGENDA 9:00 9:15 AM Welcome and Introductions TUESDAY, DECEMBER 15, 2015 9:00 AM 5:05 PM 9:15 9:45 AM Update on the Ryan White HIV/AIDS
HOME DIALYSIS THERAPIES
Conference on HOME DIALYSIS Goldwurm Auditorium 1425 Madison Avenue Course Directors John C. He, MD, PhD Peter Kotanko, MD, FASN Jaime Uribarri, MD Jointly Provided by: Department of Medicine, Division
CDC s Enhanced Comprehensive HIV Prevention Planning (ECHPP) Project:
CDC s Enhanced Comprehensive HIV Prevention Planning (ECHPP) Project: Updates from Baltimore, Philadelphia, and Washington DC Lisa Belcher, PhD Behavioral Scientist Mary Spink Neumann, PhD Behavioral Scientist
Evidence-Based Practices Symposium
Evidence-Based Practices Symposium Monday-Tuesday, June 6-7, 2011 Crowne Plaza Anaheim Welcome to CiMH's Annual Evidence-Based Practices Symposium Monday-Tuesday, June 6-7, 2010 at the Crowne Plaza Anaheim
As a result of this training, participants will be able to:
Addressing Prevention with HIV Positive Clients 1 Day Training This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result
Recommendation #1: Expand Drug Courts
The criminal justice system affords a unique opportunity to intervene with dysfunctional drug abusers in the state. Drug courts provide a way to identify and divert those juvenile and adult arrestees who
Reducing Recidivism and Promoting Recovery. Agenda. Justice and Mental Health Collaboration Program National Training and Technical Assistance Event
Bureau of Justice Assistance U.S. Department of Justice Justice and Mental Health Collaboration Program National Training and Technical Assistance Event Reducing Recidivism and Promoting Recovery Agenda
Real-time antiretroviral treatment monitoring among HIV-positive individuals in southern China: early experiences with Wisepill
Real-time antiretroviral treatment monitoring among HIV-positive individuals in southern China: early experiences with Wisepill Lora Sabin, 1 Mary Bachman DeSilva, 1 Christopher J Gill, 1 Zhong Li, 2 Taryn
Pediatric HIV/AIDS training course February 23-25, 2013
Pediatric HIV/AIDS training course February 23-25, 2013 St. Jude Children s Research Hospital Memphis, TN Dear Delegate, The American Academy of Pediatrics and the Committee on Pediatric AIDS are delighted
Alain H. Litwin, M.D., M.P.H.
Interventions to Enhance Adherence to IFN-free HCV Therapy Among People Who Inject Drugs Alain H. Litwin, M.D., M.P.H. International Network on Hepatitis in Substance Users Albert Einstein College of Medicine
National Network of STD/HIV Prevention Training Centers
National Network of STD/HIV Prevention Training Centers Rheta Barnes Chief, Training Unit Program and Training Branch Division of STD Prevention Cindy Getty Sr. Advisor for Partner Services Office of the
Christina Psaros, Ph.D. (presenting author) Massachusetts General Hospital / Harvard Medical School, Boston, MA
Evaluation and process outcomes from an adherence intervention to support HIV pre-exposure prophylaxis (PrEP) adherence in HIV serodiscordant couples in Uganda Christina Psaros, Ph.D. (presenting author)
Prevention Science and Methodology Group Meeting Johns Hopkins Bloomberg School of Public Health March 19-21, 2008
Prevention Science and Methodology Group Meeting March 19-21, 2008 This meeting of the Prevention Science and Methodology Group (PSMG) brings together leading prevention and early intervention scientists
Time Topic / Activity Presenter(s)
Social Innovation Fund Pre-Launch Training Agenda September 14, 2013 Time Topic / Activity Presenter(s) 8:00 REGISTRATION 8:30 Welcome - JAHF and AIMS Center Introductions 8:50 Agenda & Materials Review
Medication Assisted Treatment Conference
Medication Assisted Treatment Conference starting a common conversation WHEN: September 8-10 9:00am 4:00pm You are invited to attend a 3-day / 2-part training event, September 8-10, introducing best practices
2016 California Behavioral Health Policy Forum
PRELIMINARY PROGRAM 2016 California Behavioral Health Policy Forum February 17 19, 2016 Doubletree by Hilton Hotel Sacramento 2001 Point West Way Sacramento, California 95815 PROGRAM AT-A-GLANCE WEDNESDAY,
Note: Staff who work in case management programs should attend the AIDS Institute training, "Addressing Prevention in HIV Case Management.
Addressing Prevention with HIV Positive Clients This one-day training will prepare participants to help people living with HIV to avoid sexual and substance use behaviors that can result in transmitting
Applying Mobile Technology to Mental Health and Substance Use Disorders: The State of the Science
Applying Mobile Technology to Mental Health and Substance Use Disorders: The State of the Science Lisa A. Marsch, PhD Director, Dartmouth Center for Technology and Behavioral Health Director, Northeast
SeniorMed Education Forum 2008 Piecing Together Today s Senior Healthcare Puzzle. May 1, Tampa Marriott Westshore
SeniorMed Education Forum 2008 Piecing Together Today s Senior Healthcare Puzzle May 1, 2008 - Tampa Marriott Westshore SeniorMed Education Forum is a leading provider of pharmacy products and services
AHRQ Effective Health Care Program Clinical and Comparative Effectiveness Research Methods: II
AHRQ Effective Health Care Program Clinical and Comparative Effectiveness Research Methods: II June 1-2, 2009 John M. Eisenberg Building Agency for Healthcare Research and Quality AHRQ Conference Center
CHS 476/676 AIDS: Psychosocial & Health Concerns Spring Semester
CHS 476/676 AIDS: Psychosocial & Health Concerns Spring Semester Times Location Instructor Kristen Clements-Nolle, PhD, MPH Office 216 Lombardi Building Office Hours by appointment Phone 682-7097 E-mail
Welcome Please stand by. We will begin shortly.
Welcome Please stand by. We will begin shortly. SCLC and Pfizer IGLC 2015 Grantees Forum Call Wednesday, December 9, 2015 2pm ET (60 minutes) Moderator Catherine Saucedo Deputy Director, Smoking Cessation
Harm Reduction and Syringe Exchange Programs in the City and County of Los Angeles
Harm Reduction and Syringe Exchange Programs in the City and County of Los Angeles Stephen David Simon, JD City of Los Angeles, AIDS Coordinator s Office Anna Long, PhD, MPH County of Los Angeles, Department
Community Client Tracing Through Mentor Mothers in the Democratic Republic of the Congo
Innovative Approaches for Eliminating Mother-to-Child Transmission of HIV Community Client Tracing Through Mentor Mothers in the Democratic Republic of the Congo 1 Optimizing HIV Treatment Access for Pregnant
Looking to the Future in HIV Prevention:
Looking to the Future in HIV Prevention: A Health Department Perspective Angela C. Johnson, MPH, CHES Associate Director, Prevention ABOUT NASTAD WHO: A non-profit association founded in 1992 that represents
Technology to support a Community of Practice Promoting Healthy Built Environment Policies
Technology to support a Community of Practice Promoting Healthy Built Environment Policies Kim Perrotta, HCBD Knowledge Translation & Communications Heart and Stroke Foundation Health Promotion Ontario
SAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE
SAN FRANCISCO SAFE INJECTION SERVICES TASK FORCE MEETING 2 JULY 21 ST, 2017 9AM-11AM 25 VAN NESS AVE RM 610 SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH AGENDA WELCOME & AGENDA REVIEW MEETING 1 FINDINGS &
August 20-22, 2015, Los Angeles, California Final Program
Project 6 Summit SAGES TELEMENTORING INITIATIVE August 20-22, 2015, Los Angeles, California Using telementoring to virtually stand side-by-side in support of surgeons and patients in the OR. Final Program
ART FOR ART PREVENTION. Introduction of ongoing or planned trials
ART FOR ART PREVENTION Introduction of ongoing or planned trials François Dabis, MD, PhD for WHO Department of HIV/AIDS Geneva - November 3, 2009 ART FOR ART PREVENTION as of November 2009 Descriptive
Innovative Approaches for Eliminating Mother-to-Child Transmission of HIV
Innovative Approaches for Eliminating Mother-to-Child Transmission of HIV Community Client Tracing: Mentor Mothers in the Democratic Republic of the Congo The Optimizing HIV Treatment Access for Pregnant
Best Practices for Reclaiming Recovery, Resiliency, and Readiness Holiday Inn Inner Harbor, Baltimore, MD May 24-25, 2011
SAMHSA s support of behavioral health systems serving service members, veterans, and their families Best Practices for Reclaiming Recovery, Resiliency, and Readiness Holiday Inn Inner Harbor, Baltimore,
The Neurocognitive and Psychosocial Impacts of Violence and Trauma: A Workshop July 31 August 1, 2017
A WORKSHOP OF THE FORUM ON GLOBAL VIOLENCE PREVENTION: The Neurocognitive and Psychosocial Impacts of Violence and Trauma: A Workshop July 31 August 1, 2017 National Academies Building 2101 Constitution
Chagas Disease Thursday, September 14, 2017
Chagas Disease in the United States Thursday, September 14, 2017 8:00 am - 5:00 pm Price Center/Block Research Pavilion, LeFrak Auditorium Albert Einstein College of Medicine, New York and Montefiore Medical
AGENDA. Opening remarks from our state partners Lindsey Myers, CDPHE Ronne Hines, DORA Robert Werthwein, DHS/OBH Cathy Traugott, HCPF
Colorado Consortium for Prescription Drug Abuse Prevention 6 th Annual Meeting Thursday, October 25, 2018 University of Colorado Anschutz Medical Campus, Education 2 South, Room 1102 13121 E. 17 th Avenue,
An adherence intervention to support HIV pre-exposure prophylaxis (PrEP) adherence in HIV serodiscordant couples in Uganda
An adherence intervention to support HIV pre-exposure prophylaxis (PrEP) adherence in HIV serodiscordant couples in Uganda Christina Psaros, Ph.D. Massachusetts General Hospital / Harvard Medical School,
HIV Update. Under the direction of: Peter F. Weller, MD, MACP Douglas S. Krakower, MD Simi Padival, MD
JUNE 1-3, 2017 Fenway Health, Boston, Massachusetts, USA TWENTY-FIRST ANNUAL MEETING HIV Update Contemporary Issues in Management HEALTH CARE PROFESSIONALS CAN RELY ON THIS PROGRAM FOR THE LATEST UPDATES
As a result of this training, participants will be able to:
Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.
Hot Topics in. Thursday, October 5, Register Online! VindicoCME.com/ CASE CHOICE. Interactive Dinner Symposium 2.0.
Clinical Chief, /-certified Activity /-certified Activity This continuing Audience-driven, -based Learning Customized learning at your fingertips you choose case! Overview Agenda Antiretroviral rapy has
Management of Heart Failure
Management of Heart Failure Management of Heart Failure Volume 1: Medical Edited by Ragavendra R. Baliga, MD, MBA, FRCP, FACC Chief, Section of Cardiovascular Medicine, University Hospital East, Professor
HEALTH. Infectious Diseases HIV/AIDS
HEALTH Infectious Diseases HIV/AIDS HIV/AIDS Epidemic Control Providing a holistic approach to public health Controlling the spread of HIV/AIDS in the 21st Century is a global public health challenge,
Cancer Policy Advocate Training (CPAT) June 25-26, 2015 Washington, DC Washington Court Hotel. Agenda
Cancer Policy Advocate Training (CPAT) June 25-26, 2015 Washington, DC Washington Court Hotel Agenda Background Advances in cancer research have contributed to overall improvements in cancer survival rates,
Contextual overview with reference to MDG Goal 6 and projection for Post-2015
Contextual overview with reference to MDG Goal 6 and projection for Post-2015 10th Partnership Annual Conference Side Event Combating HIV and TB through a joint regional action Helsinki, Finland November
In collaboration with GLOBAL HEALTH SCIENCES, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO. Training workshop
WHO COLLABORATING CENTRE FOR HIV STRATEGIC INFORMATION ANDRIJA ŠTAMPAR SCHOOL OF PUBLIC HEALTH, SCHOOL OF MEDICINE UNIVERSITY OF ZAGREB John D. Rockefeller Street No. 4, 10 000 Zagreb, Croatia Phone: +
PCORI s Hepatitis C Workshop. Arlington, VA October 17, 2014
PCORI s Hepatitis C Workshop Arlington, VA October 17, 2014 1 Plenary Session: Review and Discussion of Prioritized CER Questions Eric B. Bass, MD Director, Johns Hopkins Evidence-based Practice Center
SASKATCHEWAN S HIV STRATEGY UPDATE
SASKATCHEWAN S HIV STRATEGY 2010-14 UPDATE The Saskatchewan HIV Strategy 2010-2014, approved in December 2010, was developed with extensive consultation with a variety of stakeholders: health regions,
Title: Should ART be provided in drug dependence treatment settings compared to referral to separate HIV care clinics?
Title: Should ART be provided in drug dependence treatment settings compared to referral to separate HIV care clinics? Contents 1. PICO question... 1 2. Search strategy... 2 3. Flow diagram of screening
Didactic Series. Update on DHHS Guidelines for HIV Treatment: Adherence to the Care Continuum
Didactic Series Update on DHHS Guidelines for HIV Treatment: Adherence to the Care Continuum Daniel Lee, MD UCSD Medical Center Owen Clinic March 8 th, 2018 1 Adherence to the Care Continuum Revised from
Committee on Medication Assisted-Treatment for Opioid Use Disorder. October 29, Time Task/Objective Leader/Moderator
Health and Medicine Division Board on Health Sciences Policy Committee on Medication Assisted-Treatment for Opioid Use Disorder October 29, 2018 Time Task/Objective Leader/Moderator OPEN SESSION 1:00pm
State HIV Allocations in Baltimore
1 State HIV Allocations in Baltimore Baltimore Part A Planning Council Maryland Department of Health and Mental Hygiene Jeffrey Hitt, MEd Director Infectious Disease Prevention and Health Services Bureau
International Network on Hepatitis in Substance Users
High Rates of Sustained Virological Response in People Who Inject Drugs Treated With Sofosbuvir-Based Regimens Alain H. Litwin, MD, MPH Kim K. Yu, MPH Linda Agyemang, MPH Jordan Wong, RPA Irene J. Soloway,
Differentiated Care for Antiretroviral Therapy for Key Populations: Case Examples from the LINKAGES Project
Differentiated Care for Antiretroviral Therapy for Key Populations: Case Examples from the LINKAGES Project NOVEMBER 2017 An estimated 37 million people are living with HIV today. A response to the need
H1N1 Vaccination Campaigns: Integrated Communication, Distribution, and Administration Strategies. A Regional Workshop Series.
Board on Health Sciences Policy Forum on Medical and Public Health Preparedness for Catastrophic Events H1N1 Vaccination Campaigns: Integrated Communication, Distribution, and Administration Strategies
Counseling Framework for HIV-serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-Exposure Prophylaxis for HIV Prevention
Counseling Framework for HIV-serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-Exposure Prophylaxis for HIV Prevention Jennifer F. Morton, Connie Celum, John Njoroge, Agnes
The Relationship Between Alcohol Use and HIV in MSM
The Relationship Between Alcohol Use and HIV in MSM Frederick L. Altice, M.D., M.A. Director of Clinical and Community Research Professor of Medicine and Public Health Yale University 0 Disclosures and
Syndemics: Part 2. July 19, Ryan P. Westergaard, MD, PhD, MPH. Division of Infectious Diseases
Syndemics: Part 2 What Infectious Disease Providers Need to Know About Addiction Treatment July 19, 2018 Ryan P. Westergaard, MD, PhD, MPH Division of Infectious Diseases University of Wisconsin School
Schroeder Institute + Mayo Clinic
Schroeder Institute + Mayo Clinic LEVERAGING TECHNOLOGY FOR SMOKING CESSATION JEFF POTERUCHA, MA, TTS AND MEGAN A. JACOBS, MPH Overview 1. Why technology in the healthcare setting? 2. Web and mobile applications
A National Perspective on Preventing Urban Violence
A National Perspective on Preventing Urban Violence Violence is not the problem of one neighborhood or group. Coming together and owning this problem and the solutions are central. -Dr. Deborah Prothrow-Stith,
Enhanced Adherence Counseling (EAC) for Adults
Enhanced Adherence Counseling (EAC) for Adults Learning Objectives To be able to conduct counselling sessions for patients with a high viral load through the identification of barriers to adherence and
Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB
February 2017 Guidance on Matching Funds: Tuberculosis Finding the Missing People with TB 1. Background TB is the leading cause of death by infectious disease, killing 1.8 million people in 2015. Each
Integrated Healthcare Association 2016 IHA Stakeholders Meeting
Integrated Healthcare Association Exhibitor & Sponsor Prospectus Friday, September 23, 2016 Hilton Los Angeles Airport Los Angeles, California CONFERENCE OVERVIEW The fifteenth annual IHA Stakeholders
Enhanced Comprehensive HIV Prevention Planning (ECHPP) Project Overview
Enhanced Comprehensive HIV Prevention Planning (ECHPP) Project Overview David W. Purcell, JD, PhD Deputy Director, Behavioral and Social Science Stephen Flores, PhD Team Lead, Prevention Research Branch
National Meeting on Precision Medicine and Cancer in
National Meeting on Precision Medicine and Cancer in AMERICAN INDIAN & ALASKA NATIVE COMMUNITIES A Dialogue on Cancer Research Remarks by Congressman Tom Cole (OK-04) and Dr. Douglas Lowy, Acting Director
Comprehensive HIV/AIDS Resources and Linkages for Inmates (CHARLI) and Care Coordination (CC) Collaborative. Care Coordination
Comprehensive HIV/AIDS Resources and Linkages for Inmates (CHARLI) and Care Coordination (CC) Collaborative CHARLI CHARLI Contract Monitor Susan Carr HIV Prevention Unit Virginia Department of Health Susan.Carr@vdh.virginia.gov
New England HIV Implementation Science Network
Common Interests/Questions/Discussion Points across the Network Work Groups Identified In the First and Second Web Meeting Summaries (December 2014 January 2015) Key population: men who have sex with men
E. Jennifer Edelman, MD, MHS David A. Fiellin, MD Yale University Schools of Medicine and Public Health
Using the Network to Develop a Successful Implementation Science Proposal: Working with HIV Clinics to adopt Addiction Treatments using Implementation Facilitation (WHAT-IF?) E. Jennifer Edelman, MD, MHS
National Newborn Screening Meeting on New Disorders [Pompe, MPS I, X-ALD]
National Newborn Screening Meeting on New Disorders [Pompe, MPS I, X-ALD] June 20-21, 2018 Washington Marriott at Metro Center Washington, DC This meeting is sponsored by the Association of Public Health
Feb 11-12, 2016 University of Southern California Los Angeles, CA. Design Agenda
The 3 rd USC Conference on Optimizing Medication Safety and Healthcare Quality: Best Practices and Collaborations for Public Health, Geriatrics, and Mental Health Feb 11-12, 2016 University of Southern
Narrative Science-based literature on Syringe Exchange Programs (SEPs)
Narrative Science-based literature on Syringe Exchange Programs (SEPs) 1996 2007 Background: In 1988, the US Department of Health and Human Services (HHS) prohibited the use of federal money to be used
Telemedicine: Connecting Behavioral Health and Medical Care
Telemedicine: Connecting Behavioral Health and Medical Care Lawrence S. Brown, Jr., MD, MPH, FASAM CEO, START Treatment & Recovery Centers Clinical Associate Professor of Medicine and Health Care and Policy
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-THIRD REGULAR SESSION April 25-27, 2018 México D.F., México OEA/Ser.L/XIV.2.63 CICAD/doc.2385/18 25 April 2018 Original: English THE OPIOID
20th Annual Conference. Frontiers in Diabetes Research: Biological Bases for Complications of Diabetes
20th Annual Conference Frontiers in Diabetes Research: Biological Bases for Complications of Diabetes Saturday, November 17, 2018 Course Directors Domenico Accili, M.D., Russell Berrie Foundation Professor
Understanding the Disparity: Predictors of Virologic Failure in Women using HAART vary by Race/Ethnicity
Understanding the Disparity: Predictors of Virologic Failure in Women using HAART vary by Race/Ethnicity Allison M. McFall, David W. Dowdy, Carla E. Zelaya, Kerry Murphy, Tracey E. Wilson, Mary A. Young,
At the end of this presentation participants will be able to:
Diagnosis, Care and Management of Persons with HIV/AIDS Lead Faculty: Jason Farley, PhD, MPH, ANP-BC, FAAN, AACRN Co-sponsors: REACH Initiative, National AETC (Hopkins), Mid-Atlantic AETC (Hopkins), JHU
Emerging Technology Open Working Group
Emerging Technology Open Working Group September 17, 2018 1 South Van Ness, Atrium San Francisco, CA 94102 1 Welcome! Linda Gerull Chief Information Officer, City & County of San Francisco 2 Open Working
Innovative Approaches for Eliminating Mother-to-Child Transmission of HIV
Innovative Approaches for Eliminating Mother-to-Child Transmission of HIV Community Mentor Mothers: Empowering Clients Through Peer Support A Spotlight on Malawi COMMUNITY MENTOR MOTHERS 1 Optimizing HIV
PS : Comprehensive HIV Prevention Programs for Health Departments
PS12-1201: Comprehensive HIV Prevention Programs for Health Departments Program Overview Erica K. Dunbar, MPH Program Leader, Health Department Initiatives National Center for HIV/AIDS, Viral Hepatitis,
Symposium Program. #CLEARsymposium17. lean-healthcare-research-symposium/
Symposium Program #CLEARsymposium17 www.clear.berkeley.edu/events/ lean-healthcare-research-symposium/ THANK YOU TO OUR SPONSORS WELCOME LETTER On behalf of the organizing committee we are delighted to
CBA. Center of Excellence. Integration of Biomedical and Behavioral Interventions for HIV Prevention
CB Capacity Building ssistance Integration of Biomedical and Behavioral Interventions for HIV Prevention The integration of biomedical and behavioral interventions in HIV prevention can be defined as addressing
EXPLORING THE IMPACT OF SEX DISCREPANCIES IN HIV TREATMENT AND CURE
EXPLORING THE IMPACT OF SEX DISCREPANCIES IN HIV TREATMENT AND CURE CECILE DELILLE LAHIRI, M.D, M.SC ASSISTANT PROFESSOR DIVISION OF INFECTIOUS DISEASES MAY 18, 2016 OUTLINE Describe discrepancy between
FINAL PROGRAM. AAOS Board Maintenance of Certification Preparation and Review Spine. November 19, Boston, MA. A. Jay Khanna, MD. 8.
AAOS Board Maintenance of Certification Preparation and Review Spine FINAL PROGRAM November 19, 2016 8.5 CME Credits Boston, MA Course Director IMPORTANT COURSE INFORMATION AAOS Board Maintenance of Certification
10:00 Chair s welcome and opening remarks Richard Caulfield, Regional Director, Association of Colleges
Programme 09:15 Registration and refreshments 10:00 Chair s welcome and opening remarks 10:15 Transforming children and young people s mental health provision Barbara Rayment, Head of Policy, Children
Positive Connections Ad Hoc Committee Meeting 9:30 am, Wednesday, October 18, 2017 Meeting Location: 2223 West Loop South, Room 416, Houston, TX 77027
Houston Area HIV Services Ryan White Planning Council Positive Connections Ad Hoc Committee Meeting 9:30 am, Wednesday, October 18, 2017 Meeting Location: 2223 West Loop South, Room 416, Houston, TX 77027
HIV/AIDS EPIDEMIOLOGY. Rachel Rivera, MD Assistant Professor Infectious Diseases UT Southwestern Medical Center November 14, 2014
HIV/AIDS EPIDEMIOLOGY Rachel Rivera, MD Assistant Professor Infectious Diseases UT Southwestern Medical Center November 14, 2014 HOUSEKEEPING ANNOUNCEMENTS AUDIO Can you hear us? You will be accessing
Implementing Evidence-based Models and Promising Practices: The Experience of Alzheimer s Disease Demonstration Grants to States (ADDGS) Programs
January 2006 Implementing Evidence-based Models and Promising Practices: The Experience of Alzheimer s Disease Demonstration Grants to States (ADDGS) Programs Executive Summary Prepared for Lori Stalbaum,
The Role of Primary Care in Addressing the Opioid Crisis in New York State
The Role of Primary Care in Addressing the Opioid Crisis in New York State September 17, 2018 8:30 AM 4:30 PM Davis Auditorium, Hess Building 1470 Madison Avenue, New York, NY 10029 Course Directors Jeffrey
New England HIV Implementation Science Network
New England HIV Implementation Science Network The Network aims to improve HIV prevention and treatment in small urban areas with a high prevalence of HIV Inaugural Symposium Mystic, Connecticut June 4,
Ovarian Cancers: Evolving Paradigms in Research and Care Report Release Wednesday, March 2, 2016
Ovarian Cancers: Evolving Paradigms in Research and Care Report Release Wednesday, March 2, 2016 Committee Membership Jerome F. Strauss, III, (Chair), Virginia Commonwealth University School of Medicine
Bukoba Combination Prevention Evaluation: Effective Approaches to Linking People Living with HIV to Care and Treatment Services in Tanzania
Bukoba Combination Prevention Evaluation: Effective Approaches to Linking People Living with HIV to Care and Treatment Services in Tanzania COUNTRY: Tanzania Tanzania has successfully implemented the standard
OBSERVATIONAL STUDIES IN A LEARNING HEALTH SYSTEM
OBSERVATIONAL STUDIES IN A LEARNING HEALTH SYSTEM An Institute of Medicine Workshop Sponsored by the Patient-Centered Outcomes Research Institute A LEARNING HEALTH SYSTEM ACTIVITY IOM ROUNDTABLE ON VALUE
Care Coach Collaborative Model Bridging Gap of Medical Linkage for HIV Positive Inmates Go home, kiss your Mother, and come into our offices. (Patsy F
Care Coach Collaborative Model Bridging Gap of Medical Linkage for HIV Positive Inmates Go home, kiss your Mother, and come into our offices. (Patsy Fitzgerald) 93% of participants in the Care Coach program
Prevention and Treatment of HIV/AIDS among Drug Using Populations: NIDA s Research Priorities
Prevention and Treatment of HIV/AIDS among Drug Using Populations: NIDA s Research Priorities Jacques Normand, Ph.D. Director, AIDS Research Program NIDA/NIH Objectives Briefly Characterize the magnitude
Assessing HIV Stigma Among Opioid- Dependent Individuals. Under Community Supervision
Assessing HIV Stigma Among Opioid- Dependent Individuals Mary Mbaba, MPH Amy Murphy, MPP Alese Wooditch, MA Suneeta Kumari, MD, MPH Faye Taxman, PhD William Lawson, MD, PhD Frederick Altice, MD, MPH Under
SBRT IN THE MANAGEMENT OF PROSTATE CANCER SATELLITE SYMPOSIUM AT THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO) 2018 ANNUAL MEETING ADVANCES IN
DEPARTMENT OF RADIATION ONCOLOGY ADVANCES IN SBRT IN THE MANAGEMENT OF PROSTATE CANCER SATELLITE SYMPOSIUM AT THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY (ASTRO) 2018 ANNUAL MEETING OCTOBER 21, 2018 MARRIOTT
Integrated HIV Statewide Coordinated Statement of Need (SCSN)/Comprehensive Plan Update
Integrated HIV Statewide Coordinated Statement of Need (SCSN)/Comprehensive Plan Update Ryan White HIV/AIDS Program Part B Administrative Reverse Site Visit November 6, 2014 Andrea Jackson, MPH, Project